Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
aControlled, adding, amplification, blocker, Boston, CCNE, Dana, dissolution, equipment, Farber, inthe, Ladenburg, round, Thalmann, thereof, underwriting
Removed:
April, authorized, cancelled, reissuance, reserved, restored, retired, SA, supply, unissued
Filing tables
Filing exhibits
Related press release
CYCC similar filings
Filing view
External links
EXHIBIT 32.1
Certification of Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. s 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cyclacel Pharmaceuticals, Inc. ( the “Company”) hereby certifies, to such officer’s knowledge, that:
| (i) | the Quarterly Report on Form10-Q of the Company for the three months ended June 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
| (ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 10, 2017 | /s/ Spiro Rombotis |
| Spiro Rombotis | |
| President & Chief Executive Officer |